Cientistas japoneses desenvolvem vitamina K aprimorada para regeneração de neurônios

27 de maio de 2026

Reportado por IA

Pesquisadores no Japão criaram novos compostos de vitamina K que são três vezes mais eficazes do que as formas naturais na conversão de células-tronco em neurônios. O trabalho, publicado em 2025, visa doenças que destroem células cerebrais, como Alzheimer e Parkinson.

O professor associado Yoshihisa Hirota e o professor Yoshitomo Suhara lideraram a equipe no Instituto de Tecnologia de Shibaura. Eles combinaram vitamina K com elementos da vitamina A para produzir 12 moléculas híbridas. Um composto, chamado Novel VK, destacou-se em testes com células progenitoras neurais de camundongos por sua forte capacidade de promover o crescimento neuronal.

McGill researchers use reversible drug approach to boost natural killer cells against hard-to-treat cancers

25 de maio de 2026 Reportado por IA Imagem gerada por IA Verificado

Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.

Cambridge study reveals potential to reverse nerve damage

Researchers at the University of Cambridge have developed miniature lab-grown models of the human brain and spinal cord that show damaged nerve fibers can regain the ability to regrow under certain conditions.

Anti-aging drug combo damages myelin in mouse brains

27 de maio de 2026 Reportado por IA

A widely studied anti-aging treatment triggered significant brain damage in mice, according to new research from the University of Connecticut. The drug combination dasatinib plus quercetin caused myelin loss and changes resembling those seen in multiple sclerosis. The findings raise questions about its use in longevity studies and off-label therapies.

Saúde

Study finds lower normal B12 levels tied to brain changes

Ásia

Japan's ministry approves world's first iPS cell treatments for heart failure and Parkinson's

Saúde

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Hong Kong researchers develop world-first nasal spray for stroke aid

Researchers at the University of Hong Kong have developed a world-first nasal spray that delivers neurotherapeutic powder directly to the brain as first aid for ischemic stroke patients. The treatment, named NanoPowder, is designed to reduce brain damage by more than 80 per cent and improve stroke survival rates. Clinical trials are expected by 2030.

Northwestern engineers print artificial neurons that can stimulate living brain cells

18 de abril de 2026 Reportado por IA Verificado

Northwestern University researchers report they have printed flexible “artificial neurons” that generate realistic electrical spike patterns and can trigger responses in living mouse brain tissue. The team says the work, published April 15 in Nature Nanotechnology, could help advance brain-machine interfaces and more energy-efficient, brain-inspired computing.

domingo, 24 de maio de 2026, 10:34h

Cientistas japoneses desenvolvem vitamina K aprimorada para regeneração de neurônios

Artigos relacionados

McGill researchers use reversible drug approach to boost natural killer cells against hard-to-treat cancers

Cambridge study reveals potential to reverse nerve damage

Anti-aging drug combo damages myelin in mouse brains

Study finds lower normal B12 levels tied to brain changes

Japan's ministry approves world's first iPS cell treatments for heart failure and Parkinson's

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Hong Kong researchers develop world-first nasal spray for stroke aid

Northwestern engineers print artificial neurons that can stimulate living brain cells

Duke-led Nature study links glia-to-neuron mitochondria transfer to reduced nerve pain in neuropathy models

Rebooting stem cells builds bigger muscles in aged mice

Swedish team restores blood sugar control in diabetic mice

Personalized treatment plans improve early dementia symptoms

Higher midlife vitamin D levels linked to lower brain tau protein

Canadian researchers uncover brain cells fueling glioblastoma growth

Este site usa cookies